Mural Oncology PLC Logo

Mural Oncology PLC

Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.

MURA | BUD

Overview

Corporate Details

ISIN(s):
IE000LK2BOB4
LEI:
Country:
Ireland
Address:
N/A
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Mural Oncology PLC is a clinical-stage oncology company focused on developing novel immunotherapies to treat cancer. The company leverages its proprietary protein engineering platform and expertise in cytokine biology to design and advance a pipeline of cytokine-based therapies. Its mission is to unlock the value of immunotherapy for a broader range of patients, particularly those with cancers that have not responded to previous treatments. The company's lead candidate, nemvaleukin alfa, is a novel, engineered interleukin-2 (IL-2) variant immunotherapy currently in clinical trials for difficult-to-treat solid tumors, including advanced melanoma and platinum-resistant ovarian cancer.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-24 22:25
Post-Annual General Meeting Information
Mural Oncology Announces that Mural Shareholders Approve the Proposed Acquisiti…
English 31.3 KB
2025-09-24 01:52
Proxy Solicitation & Information Statement
Mural Oncology Announces Commencement of Mailing of Definitive Proxy Statement …
English 18.3 KB

Automate Your Workflow. Get a real-time feed of all Mural Oncology PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Mural Oncology PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Mural Oncology PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.